Press release
Respiratory Inhaler Devices Global Market Size is Expected to Grow $54.72 Billion at a CAGR of 7.3% By 2028 | Key Players: Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M
Respiratory Inhaler Devices Market
The Business Research Company's Respiratory Inhaler Devices Global Market Report 2023 identifies the growing prevalence of respiratory diseases is expected to propel the growth of the respiratory inhaler devices market going forward. Respiratory diseases are disorders that affect the lungs and the respiratory system, leading to breathing difficulties and impaired lung function.
The respiratory inhaler devices market size has grown strongly in recent years. It will grow from $38.54 billion in 2023 to $41.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to smoking epidemic, allergic disorders, pharmaceutical innovation, aging population. The respiratory inhaler devices market size is expected to see strong growth in the next few years. It will grow to $54.72 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%.
Download Free Sample Of Respiratory Inhaler Devices Market Report -
https://www.thebusinessresearchcompany.com/sample_request?id=13014&type=smp
Major players in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healthcare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc.
The rise in smoking rates is expected to propel the growth of the respiratory inhaler devices market in the coming years. Smoking is the process of inhaling and exhaling the vapors of a burning plant substance, most frequently tobacco, as inhaled in a cigarette, cigar, or pipe.
Read More On The Global Respiratory Inhaler Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
The Respiratory Inhaler Devices market is segmented -
1) By Product: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Technology: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
3) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Other Indications
4) By End User: Hospitals And Clinics, Respiratory Care Centers, Other End Users Services And Insurance (BFSI), Government, Healthcare, Manufacturing, Retail And Logistics, Other End-User Industries
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Respiratory Inhaler Devices market.
The Business Research Company's "Global Respiratory Inhaler Devices Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Respiratory Inhaler Devices Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13014
The Table Of Content For The Respiratory Inhaler Devices Market Include:
1. Executive Summary
2. Respiratory Inhaler Devices Market Characteristics
3. Respiratory Inhaler Devices Market Trends And Strategies
4. Respiratory Inhaler Devices Market - Macro Economic Scenario
5. Respiratory Inhaler Devices Market Size And Growth
……
27. Respiratory Inhaler Devices Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Respiratory Inhaler Devices Market
29. Respiratory Inhaler Devices Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Respiratory Inhaler Devices Global Market Size is Expected to Grow $54.72 Billion at a CAGR of 7.3% By 2028 | Key Players: Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M here
News-ID: 3327967 • Views: …
More Releases from The Business research company
Top Players and Competitive Environment in the Carbon Dioxide Recycling Methanol …
The carbon dioxide recycling methanol market is poised for remarkable expansion as the world intensifies efforts toward sustainability and carbon neutrality. With increasing emphasis on reducing greenhouse gas emissions and boosting renewable energy sources, this market is set to play a pivotal role in the global transition to cleaner fuels and circular carbon economies. Here's a detailed look at its projected growth, influential players, emerging trends, and segmentation.
Forecasted Market Growth…
Emerging Sub-Segments Transforming the Caprolactam Market Landscape
The caprolactam market is set for significant expansion in the coming years, driven by evolving industrial needs and sustainability initiatives. This report delves into the anticipated growth, key players, emerging trends, and detailed market segmentation to offer a comprehensive view of the sector's future trajectory.
Caprolactam Market Size Forecast Through 2030
The caprolactam market is projected to reach a value of $24.38 billion by 2030, growing at a compound annual…
Emerging Growth Patterns Driving Expansion in the Butyl Acrylate Market
The butyl acrylate market is gaining considerable attention as industries increasingly seek versatile chemical compounds to enhance their products. With its broad utility across coatings, adhesives, and textiles, the market is set for significant growth in the coming years. Let's explore the current market size, the main players, key trends, and segment insights shaping this industry.
Projected Market Size and Growth in Butyl Acrylate
The butyl acrylate market is poised…
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Bo …
Boron nitride coatings are gaining increased attention due to their versatile applications and enhanced protective qualities. As industries like automotive, aerospace, and electronics evolve, the demand for advanced coating solutions that can withstand extreme conditions is rising. This overview explores the current market size, key players, important trends, and dominant segments shaping the boron nitride coatings market.
Strong Market Growth Expected for Boron Nitride Coatings by 2030
The boron nitride…
More Releases for Inhaler
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg
Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for…
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as…
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma…
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for…
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the…
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…
